NCT07543172 2026-04-21
CIMAvax-EGF With KRAS G12C Inhibitor for the Treatment of Advanced, KRAS G12C Mutated Non Small Cell Lung Cancer
Roswell Park Cancer Institute
Phase 2 Not yet recruiting
Roswell Park Cancer Institute
National Cancer Institute (NCI)
Ohio State University Comprehensive Cancer Center
Roswell Park Cancer Institute
University of Washington
SWOG Cancer Research Network
Alliance for Clinical Trials in Oncology
IRCCS San Raffaele